Such a response is how the body fights against bacteria, viruses, fungi or parasites
2025-08-28T09:15:44 Steris Healthcare Pvt Ltd
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats Johansen PB, Nowak J, Skjaerbaek C, et al
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
* These statements have not been evaluated by the Food and Drug Administration
doi: 10.1007/s00125-017-4315-2 135 HeiseTMariADeVriesJHUrvaSLiJPrattEJet al
